BetterLife Pharma (BETRF) Capital Expenditures Growth (1y) (2021)
Powered by 
Analysis
BetterLife Pharma (BETRF) Capital Expenditures Growth (1y) (2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.69 Bn | 192.70 Bn | 7.24 Bn | 39.02% |
| 2 | Gilead Sciences | 179.87 Bn | 176.70 Bn | 6.22 Bn | 30.84% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -22.99% |
| 4 | Regeneron Pharmaceuticals | 81.70 Bn | 73.71 Bn | 3.93 Bn | 9.68% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.28 Bn | 49.14 Bn | 52.00 Mn | 1,133.33% |
| 7 | Alnylam Pharmaceuticals | 33.02 Bn | 29.71 Bn | 992.69 Mn | 142.64% |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 53.76% |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | - |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - | - |